Provider comparison

Surfbound Health vs WeightCare

One molecule can be compared here and one cannot. The one that cannot says something more useful than a number would: the program advertises a free consultation and does not confirm the fee is zero.

Provider pages read 30 Oct 2026Rechecked monthly

Short answer

Is Surfbound Health or WeightCare cheaper for compounded GLP-1 injections?

On tirzepatide, no eligible standard monthly price is recorded for WeightCare, so the other program’s figure stands alone on that molecule. On semaglutide the recorded monthly charges are $169 at Surfbound Health and $399 at WeightCare. $230 a month lower at Surfbound Health, about 58% less than $399.

On compounded semaglutide the comparison is clean. Both programs bill a single period at a time, both record no separate membership fee, and both include the provider review, medication and shipping inside the charge. Surfbound Health holds the lower recorded monthly charge, and the amounts and the date each was read are printed in the table below.

On compounded tirzepatide there is no comparison to print, and the reason is not a missing page. WeightCare records $499 a month for doses up to 7.5 mg, and its own terms state that a one-time consultation fee may apply. A free consultation is advertised, but a zero fee is not confirmed. This site treats a required fee with no published amount as unknown rather than zero, so the $499 figure is not printed as an out-the-door monthly price.

That distinction is worth more than a tidier table. A buyer setting a $499 headline against another program’s all-in charge would be comparing a number that may carry a further charge against one that does not. The row states the position instead of resolving it in either program’s favour.

The second thing to know about WeightCare is where its monthly price stops. The monthly rate is recorded for doses up to 7.5 mg, and no monthly rate above that dose is recorded. The program also sells a three-month high-dose term at $1,350, and three-, six- and twelve-month terms at about $299, $275 and $216 a month, but every one of those is a charge for a term rather than a monthly instalment, so none of them is used to fill the gap.

Common ownership, disclosed before the comparison

Surfbound Health is operated by the company that operates this guide

GLP1 Buyer Guide and Surfbound Health are both owned by Open Water Rx LLC. When this guide names Surfbound Health, it is naming a program the guide’s own owner also runs and earns from, so we state that commercial interest wherever a Surfbound option appears, not only on the disclosures page.

Both programs on this page are recorded on the same fields from their own published pages, and the lower figure is named on each molecule whoever publishes it. WeightCare is not connected to this guide in any way. Full ownership, advertising and placement statement.

The monthly price, molecule by molecule

Both figures below are standard ongoing monthly charges for one billing period, not first-month, promotional or prepaid amounts. On the semaglutide row each is a regular monthly plan; on tirzepatide the competitor side states why no comparable charge is published.

Recorded standard monthly charge for one injectable plan, including every mandatory recurring fee. Each figure carries the date the provider page behind it was checked.
Medication	Surfbound Health	WeightCare	Difference
TirzepatideCompounded injectable	$219a month · checked October 22, 2026	Not establishedno eligible monthly price recorded	No eligible monthly price recorded on one side
SemaglutideCompounded injectable	$169a month · checked October 22, 2026	$399a month · checked October 26, 2026	Lower at Surfbound Health$230 a month lower at Surfbound Health, about 58% less than $399.

Kept out of that table on purpose: WeightCare’s three-, six- and twelve-month terms and its $1,350 three-month high-dose term, each of which is a charge for a term rather than a monthly instalment, and the discounted or introductory amounts either program may advertise, which are entry prices rather than recurring rates.

The two charges do not cover the same length of time: Surfbound Health bills every 28 days, while WeightCare bills once a month. A four-week cycle repeats more often in a year than a calendar month does, so the recorded gap between the two charges is not a like-for-like monthly saving, and no annual total is printed here because neither program bills one.

What the charge includes, and how you leave

The terms decide how much of each figure a buyer can rely on: what the charge covers, where the monthly price stops following the dose, and how a plan ends.

Program terms as recorded from each provider's own pages. Where a program sells two molecules, both are named rather than merged into one figure.
Field	Surfbound Health	WeightCare
Membership fee	$0: no separate membership fee	$0: no separate membership fee
Included services	Provider review, prescribed medication and shipping.	Tirzepatide: Physician support, medication if prescribed, supplies and delivery. · Semaglutide: Provider review, medication if prescribed, supplies and shipping.
Required or separate fees	No separate membership fee. No laboratory services are provided or billed.	Tirzepatide: A one-time consultation fee may apply; free consultation and delivery are advertised. · Semaglutide: No separate membership fee recorded.
Dose increases	One price across the doses listed; no advertised dose-based increase. Recorded doses: Same published price at each prescribed dose; numeric range not established	Tirzepatide: The recorded charge steps up with the dose. Recorded doses: Up to 7.5 mg at the $499 monthly rate. No monthly rate above 7.5 mg is recorded. · Semaglutide: One price across the doses listed; no advertised dose-based increase. The published dose range is not established.
Billing interval	Every 28 days.	Monthly billing.
Commitment	No long-term commitment and no minimum term. Recurring billing applies until you cancel, so the plan can be stopped before the next renewal. The published Refund Policy and Terms were re-checked on October 26, 2026.	Tirzepatide: Monthly plan renews each period; longer plans carry a term. · Semaglutide: No long-term commitment. Recurring billing applies until you cancel.
Cancellation	Cancel in the patient portal with no required advance notice and no cancellation fee; the published Refund Policy and Terms were re-checked on October 26, 2026. Cancellation stops future orders, not orders the pharmacy has already processed.	Cancel before the next renewal to stop future charges.
Refund conditions	No charge if declined; any amount collected for a declined order is refunded. Pharmacy-processed orders are nonrefundable, subject to policy exceptions.	Not established.
Dispensing pharmacy	Section 503A compounding pharmacy recorded. Surfbound Health publicly identifies several independent pharmacy partners, including Emerald Compounding Pharmacy. The specific pharmacy fulfilling an individual prescription is determined through the prescription and fulfillment process.	Not established. No dispensing facility is recorded for this program on the pages we read, so no pharmacy is attributed here.

Membership fee. A separate membership is a recurring charge billed on top of the medication. Zero means the program states no separate membership fee, which is not the same fact as an unrecorded amount.

Included services. The services the program states are inside the single charge, in the provider’s own wording.

Required or separate fees. Read from each program’s published terms. Where a fee is conditional or charged once, the record names it here rather than folding it into the charge.

Dose increases. A flat price is a claim that the charge does not rise as the dose increases. It is only established across the doses each program publishes, so the recorded ladder or dose scope is stated beside it.

Billing interval. The interval the provider actually bills on, recorded on each offer and not inferred from the medication supply. A 28-day cycle is not a calendar month, and neither is converted into the other.

Commitment. What the plan records about a minimum term, in the program’s own words. A recurring charge on its own proves neither a minimum term nor the absence of one.

Cancellation. Cancelling stops future orders. It does not reverse an order the pharmacy has already processed on either program.

Refund conditions. A refund is a different question from a cancellation: cancelling stops future charges, while a refund depends on what has already been paid, prepared or shipped. Where a program records a processing charge against a cancellation, it appears here.

Dispensing pharmacy. A pharmacy category describes how a compounded product is regulated. It does not identify the named facility filling a specific order, and it says nothing about the price.

Billing basis, Surfbound Health. Owner-confirmed on October 22, 2026 and corrected on November 11, 2026: billed every 28 days, not once a calendar month.

Billing basis, WeightCare. Provider states monthly billing; no fixed day count is published.

Where the WeightCare record is clearer, and where it stops

WeightCare publishes a regular monthly rate on semaglutide rather than a starting point, which is the one molecule on which a like-for-like comparison exists. What the record cannot supply is the same figure for tirzepatide, or a rate above the 7.5 mg band.

Where WeightCare does better

Records its compounded semaglutide plan at a regular monthly rate, stated separately from the longer prepaid terms it also publishes.
Bills a month at a time with no separate membership fee, so the plan price is the whole recurring cost on that molecule.
Publishes longer three-, six- and twelve-month terms that lower the cost per month for a buyer who commits to a term and pays it up front.
Records cancellation before the next renewal to stop future charges, with no term to buy out on the monthly plan.

Where Surfbound Health does better

Holds the lower standard monthly charge on the one molecule both programs record a comparable figure for.
Prices compounded tirzepatide with no unquantified required fee beside the charge, where the other program leaves a consultation amount unconfirmed.
Publishes one flat charge with no advertised dose-based increase, where the other program’s monthly tirzepatide rate is recorded only up to 7.5 mg.
Records compounded semaglutide and tirzepatide as comparable monthly plans, where the other program’s tirzepatide rate cannot be stated as a monthly price.
Records cancellation in the patient portal with no required advance notice and no cancellation fee.

Where the two are level. Both programs bill one period at a time, both record no separate membership fee, and both include the provider review, medication and shipping inside the charge. On supply they differ: Surfbound Health records a 28-day supply per charge, while WeightCare leaves the days of medication per charge unestablished. Neither record names the specific pharmacy filling an order.

Both programs also carry a place in the buyer guide index, read from that index rather than assigned here: Surfbound Health at rank 1 with 94.3 out of 100, and WeightCare at rank 21 with 69.1 out of 100. No position or score was changed for this page.

What would change the answer. Two recorded facts would change this page, and neither needs a new program. A confirmed zero on WeightCare’s consultation fee would make the tirzepatide row printable without any other change, and a published monthly rate above 7.5 mg would extend the comparison past the dose the current record stops at. Until one of those exists, the row says so.

What value does not mean. This is a comparison of price and program terms. It is not a clinical comparison, neither program is claimed to work better than the other, and whether a compounded medication is appropriate is a decision for a licensed prescriber.

The tirzepatide row is the one to watch. Where both programs price both molecules, it carries the larger charge of the two, so a change there moves the monthly bill further than the same change would on the other molecule.

What this comparison does not establish

WeightCare does not publish an amount for the one-time consultation fee its terms say may apply, so its tirzepatide monthly rate cannot be stated as an out-the-door price.

WeightCare’s monthly tirzepatide rate is recorded for doses up to 7.5 mg only. No monthly rate above 7.5 mg is recorded, and the higher-dose option on the record is a prepaid three-month term at $1,350, which is a charge for a term rather than a monthly price.

WeightCare does not publish the days of medication a monthly charge buys, where Surfbound Health records a 28-day supply, and neither record names the specific dispensing pharmacy behind an individual order.

Both products are compounded preparations, which are not FDA-approved and are not generic versions of any brand-name medication.

Compounded and brand-name products appear together because buyers compare them. They can share an active ingredient; they are not the same product. Compounded medications are not FDA-approved and are not generic versions of the brand-name medications.

How these figures were checked

WeightCare’s figures are read from its own pricing page and carried with the date each was read. Where a record carries a required fee with no published amount, the comparison states that rather than filling the fee in as zero, because an unconfirmed zero and a confirmed one are different facts and only one of them can be subtracted from a headline price.

Each program’s own pricing page was read for this comparison. Every figure below keeps the check date printed beside it rather than a single freshness badge for the page. A recorded figure is kept until a re-read replaces it, and a replaced figure keeps the date of the reading it came from instead of being quietly overwritten.

Read the field definitions on program cost research, the sourcing rule on how we compare, and the full monthly comparison ledger for the same fields across every recorded program.